The global oxaliplatin injection market is expected to grow at a significant CAGR during the forecast period. Oxaliplatin, also known as Eloxatin, is a cancer treatment that is used to treat colorectal cancer. In advanced cancer, it’s frequently used with fluorouracil and folinic acid. It is administered through a venous injection. The rising prevalence of colorectal cancer owing to sedentary lifestyles such as obesity, consumption of alcohol, lack of physical activity, and tobacco consumption has been the major factor driving the market growth. Colorectal cancer is the fourth leading cause of cancer-related mortalities globally. As per the World Health Organization (WHO), the number of new colorectum cancer patients of both sexes of all ages in 2020 was around 1.9 million globally, which is 10% of new cancer cases.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/oxaliplatin-injection-market
Additionally, the increasing geriatric population and rising colorectal cancer associated with them is another factor driving the market growth. Moreover, the high prevalence of smokers and alcohol consumers who are most prone to this cancer has been boosting the market. For instance, as per the Centers for Disease Control and Prevention, in 2019, around 14 of every 100 US adults of age 18 years or above smoked cigarettes, which is 14% or 34.1 million adults. Apart from this, in November 2020, Swedish cancer society received grants for nearly $2 million for two research projects concerning colorectal cancer. Thus, the rising prevalence of cancer coupled with investment and grants for cancer research and treatment is expected to further contribute to the growth of the global oxaliplatin injection market.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered
- Regions Covered- Globally
Competitive Landscape: Pfizer Inc., Sun Pharmaceutical Industries Ltd., Sanofi SA, and Teva Pharmaceuticals Industries Ltd. among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominates the market in base year?
- Which segment and region will project fastest growth in the market?
- How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Oxaliplatin Injection Market Report by Segment
By Type
- Mannitol
- Glucose Solution
- Lactose Solution
- Others
By Application
- Colorectal Cancer
- Stomach Cancer
- Ovarian Cancer
- Others
A full report of Oxaliplatin Injection Market is available at: https://www.omrglobal.com/industry-reports/oxaliplatin-injection-market
Oxaliplatin Injection Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd.
- Sanofi SA
- Teva Pharmaceuticals Industries Ltd.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
